Direkt zum Inhalt

Wagner, Andrea ; Maderer, Jonas ; Wilfling, Sibylle ; Kaiser, Johanna ; Kilic, Mustafa ; Linker, Ralf A. ; Schebesch, Karl-M. ; Schlachetzki, Felix

Cerebrovascular risk factors in cerebral amyloid angiopathy – modifier or bystander?

Wagner, Andrea, Maderer, Jonas, Wilfling, Sibylle, Kaiser, Johanna, Kilic, Mustafa , Linker, Ralf A., Schebesch, Karl-M. and Schlachetzki, Felix (2021) Cerebrovascular risk factors in cerebral amyloid angiopathy – modifier or bystander? Frontiers in Neurology 2021 (12), p. 676931. (Submitted)

Date of publication of this fulltext: 13 Aug 2021 15:47
Article
DOI to cite this document: 10.5283/epub.45163


Abstract

Goal: Cerebral amyloid angiopathy (CAA) is a frequent cause of atypical intracerebral hemorrhage (ICH) in the elderly. Stroke risk factors such as arterial hypertension (AHT), atrial fibrillation (AFib), diabetes mellitus (DM), and renal dysfunction (RD) are increasingly apparent in these patients. In this retrospective study, we analyzed the presence of these stroke risk factors in different ...

Goal: Cerebral amyloid angiopathy (CAA) is a frequent cause of atypical intracerebral hemorrhage (ICH) in the elderly. Stroke risk factors such as arterial hypertension (AHT), atrial fibrillation (AFib), diabetes mellitus (DM), and renal dysfunction (RD) are increasingly apparent in these patients. In this retrospective study, we analyzed the presence of these stroke risk factors in different initial CAA presentations comprising cerebral microbleeds (CMB), acute ischemic stroke (AIS), cortical superficial hemosiderosis (cSS), or lobar ICH (LICH) and evaluated their influence on the initial clinical presentation of patients with CAA. Material and Methods: We identified patients with at least possible CAA defined by the modified Boston criteria admitted to the Department of Neurology or Neurosurgery from 2002 to 2018. Findings: In the overall cohort of 209 patients, we analyzed the correlation between the number of stroke risk factors and the initial clinical presentation of patients with CAA and could show the high multimorbidity of the collective. There are large differences between the subgroups with different initial clinical presentations, e.g., patients with CMB as initial CAA presentation have the highest number of cerebrovascular risk factors and recurrent AIS, whereas AFib is more frequent in the Neurosurgery Department. Conclusion: There is a distinct overlap between the subgroups of CAA manifestations and stroke risk factors that need to be verified in larger patient collectives. Since these comorbidities are likely to influence the clinical course of CAA, they represent possible targets for secondary prevention until specific treatment for CAA becomes available.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleFrontiers in Neurology
Publisher:Frontiers
Place of Publication:LAUSANNE
Volume:2021
Number of Issue or Book Chapter:12
Page Range:p. 676931
Date21 July 2021
InstitutionsMedicine > Lehrstuhl für Neurochirurgie
Medicine > Lehrstuhl für Neurologie
Identification Number
ValueType
10.3389/fneur.2021.676931DOI
KeywordsBLOOD-PRESSURE CONTROL; INTRACEREBRAL HEMORRHAGE; SUPERFICIAL SIDEROSIS; ATRIAL-FIBRILLATION; STROKE; DISEASE; MICROBLEEDS; PREVALENCE; DEMENTIA; STENOSIS; cerebral amyloid angiopathy; intracerebral hemorrhage; long term outcome; risk factors (cardiovascular) comorbidities; computer tomography; magnetic resonance imaging
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusSubmitted
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
URN of the UB Regensburgurn:nbn:de:bvb:355-epub-451639
Item ID45163

Export bibliographical data

Owner only: item control page

nach oben